4//SEC Filing
GENAERA CORP 4
Accession 0000880431-08-000021
CIK 0000880431operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 11:49 AM ET
Size
12.0 KB
Accession
0000880431-08-000021
Insider Transaction Report
Form 4
GENAERA CORPGENR
Kaye Mitchell D
Director10% Owner
Transactions
- Purchase
Common Stock, Par Value $0.002
2008-05-29$2.11/sh+5,000$10,550→ 4,125,117 total(indirect: See Footnotes) - Purchase
Common Stock, Par Value $0.002
2008-05-30$1.95/sh+26,700$51,950→ 4,151,817 total(indirect: See Footnotes) - Award
Stock Option (Right to Buy)
2008-05-29+3,333→ 3,333 totalExercise: $2.20From: 2009-05-29Exp: 2018-05-29→ Common Stock, Par Value $0.002 (3,333 underlying)
Footnotes (5)
- [F1]The options were granted under the 2004 Stock-Based Incentive Compensation Plan.
- [F2]The options vest at the following rate: 833 on May 29, 2009, May 29, 2010 and May 29, 2011 and 834 on May 29, 2012.
- [F3]As of May 30, 2008, Xmark Opportunity Fund, L.P., a Delaware limited partnership ("Opportunity LP"), held 680,565 common shares, $0.002 par value per share (the "Common Shares"), of Genaera Corporation, a Delaware corporation (the "Company"), and warrants to purchase up to 210,375 Common Shares of the Company at an exercise price of $3.6606 per share and up to 12,500 Common Shares of the Company at an exercise price of $18.90 per share. All of the warrants provide that the holder does not have the right to exercise any portion of the warrant, to the extent that after giving effect to such exercise, such holder would beneficially own in excess of 4.99% of the number of Common Shares of the Company outstanding immediately after giving effect to such exercise.
- [F4]As of May 30, 2008, Xmark Opportunity Fund, Ltd., a Cayman Islands exempted company ("Opportunity Ltd"), held 1,732,305 Common Shares of the Company and warrants to purchase up to 411,205 Common Shares of the Company at an exercise price of $3.6606 per share and up to 12,500 Common Shares of the Company at an exercise price of $18.90 per share. As of May 30, 2008, Xmark JV Investment Partners, LLC, a Delaware limited liability company ("JV Partners"), held 1,738,947 Common Shares of the Company and warrants to purchase up to 27,500 Common Shares of the Company at an exercise price of $18.90 per share. All of the warrants provide that the holder does not have the right to exercise any portion of the warrant, to the extent that after giving effect to such exercise, such holder would beneficially own in excess of 4.99% of the number of Common Shares of the Company outstanding immediately after giving effect to such exercise.
- [F5]Xmark Opportunity Partners, LLC, a Delaware limited liability company ("Opportunity Partners"), is the sole member of the investment manager of Opportunity LP and Opportunity Ltd, and the investment manager of JV Partners, and, as such, possesses sole power to vote and direct the disposition of all securities of the Company held by Opportunity LP, Opportunity Ltd and JV Partners. The reporting person's interest in the securities reported herein is limited to the extent of his pecuniary interest in Opportunity LP, Opportunity Ltd and JV Partners, if any. Mitchell D. Kaye and David C. Cavalier, the Chief Executive Officer and Chief Operating Officer, respectively, of Xmark Capital Partners, LLC, the Managing Member of Opportunity Partners, share voting and investment power with respect to all securities beneficially owned by Opportunity Partners.
Documents
Issuer
GENAERA CORP
CIK 0000880431
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000880431
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 11:49 AM ET
- Size
- 12.0 KB